A detailed history of Granite Investment Partners, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Granite Investment Partners, LLC holds 37,471 shares of LLY stock, worth $29.8 Million. This represents 1.47% of its overall portfolio holdings.

Number of Shares
37,471
Previous 38,177 1.85%
Holding current value
$29.8 Million
Previous $34.6 Million 3.95%
% of portfolio
1.47%
Previous 1.49%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$772.14 - $960.02 $545,130 - $677,774
-706 Reduced 1.85%
37,471 $33.2 Million
Q2 2024

Aug 12, 2024

SELL
$724.87 - $909.04 $46,391 - $58,178
-64 Reduced 0.17%
38,177 $34.6 Million
Q1 2024

May 13, 2024

SELL
$592.2 - $792.28 $1.87 Million - $2.51 Million
-3,163 Reduced 7.64%
38,241 $29.7 Million
Q4 2023

Feb 14, 2024

SELL
$525.19 - $619.13 $181,190 - $213,599
-345 Reduced 0.83%
41,404 $24.1 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $648,137 - $893,556
1,491 Added 3.7%
41,749 $22.4 Million
Q2 2023

Aug 07, 2023

BUY
$350.74 - $468.98 $949,803 - $1.27 Million
2,708 Added 7.21%
40,258 $18.9 Million
Q1 2023

May 03, 2023

SELL
$310.63 - $364.82 $5.06 Million - $5.94 Million
-16,293 Reduced 30.26%
37,550 $12.9 Million
Q4 2022

Feb 10, 2023

BUY
$321.55 - $374.67 $294,539 - $343,197
916 Added 1.73%
53,843 $19.7 Million
Q3 2022

Oct 24, 2022

SELL
$296.48 - $337.87 $4.5 Million - $5.12 Million
-15,164 Reduced 22.27%
52,927 $17.1 Million
Q2 2022

Jul 22, 2022

BUY
$278.73 - $327.27 $2.66 Million - $3.12 Million
9,539 Added 16.29%
68,091 $22.1 Million
Q1 2022

May 02, 2022

BUY
$234.69 - $291.66 $319,413 - $396,949
1,361 Added 2.38%
58,552 $16.8 Million
Q4 2021

Feb 10, 2022

BUY
$224.85 - $279.04 $12.9 Million - $16 Million
57,191 New
57,191 $15.8 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.